Dennis M. Miller is an accomplished inventor based in Woodinville, WA (US). He has made significant contributions to the field of biotechnology, particularly in the development of peptide-based therapies. With a total of five patents to his name, Miller's work focuses on targeted drug delivery systems that enhance the efficacy of treatments for various medical conditions.

Latest Patents

Miller's latest patents include innovative technologies such as tissue-homing peptide conjugates and methods of use thereof. These peptides are designed to home, target, and bind to specific tissues, such as cartilage or kidney, allowing for targeted delivery of active agents. Another notable patent involves tumor homing and cell penetrating peptide-immuno-oncology agent complexes. These complexes are capable of targeting the tumor microenvironment and can even cross the blood-brain barrier, providing new avenues for cancer treatment.

Career Highlights

Miller is currently associated with Blaze Bioscience, Inc., where he continues to push the boundaries of peptide technology. His work has the potential to revolutionize how therapies are delivered, making treatments more effective and reducing side effects.

Collaborations

Miller collaborates with talented professionals in his field, including Natalie Winblade Nairn and Julia E. Novak. These partnerships enhance the innovative capacity of his projects and contribute to the advancement of biotechnology.

Conclusion

Dennis M. Miller's contributions to peptide technology and targeted drug delivery systems mark him as a significant figure in the field of biotechnology. His innovative patents and collaborations continue to pave the way for advancements in medical treatments.

This text is generated by artificial intelligence and may not be accurate.